10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
Clinical trial NCT02959255 · COMPLETED
Trial details
- NCT number
- NCT02959255
- Sponsor
- Elpen Pharmaceutical Co. Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-30
- Primary completion
- 2017-12-30
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.